Natriuretic peptides - Biomarker companions through thick and thin
- PMID: 38287692
- DOI: 10.1002/ejhf.3153
Natriuretic peptides - Biomarker companions through thick and thin
References
-
- Maeder MT, Mariani JA, Kaye DM. Hemodynamic determinants of myocardial B‐type natriuretic peptide release: Relative contributions of systolic and diastolic wall stress. Hypertension 2010;56:682–689. https://doi.org/10.1161/HYPERTENSIONAHA.110.156547
-
- Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004;109:594–600. https://doi.org/10.1161/01.CIR.0000112582.16683.EA
-
- Obokata M, Reddy YNV, Melenovsky V, Sorimachi H, Jarolim P, Borlaug BA. Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity. Eur J Heart Fail 2022;24:353–361. https://doi.org/10.1002/ejhf.2377
-
- Patel SM, Morrow DA, Bellavia A, Berg DD, Bhatt DL, Jarolim P, Leiter LA, McGuire D, Raz I, Steg PG, Wilding JPH, Sabatine MS, Wiviott SD, Braunwald E, Scirica BM, Bohula EA Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR‐TIMI 53, DECLARE‐TIMI 58 and CAMELLIA‐TIMI 61. Eur J Heart Fail 2024;26:260–269. https://doi.org/10.1002/ejhf.3118
-
- Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, et al.; SAVOR‐TIMI 53 Steering Committee and Investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 2013;369:1317–1326. https://doi.org/10.1056/NEJMoa1307684
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical